| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |